New research links tattoos to increased melanoma skin cancer risk Tattoos might seem like harmless self-expression, but could they secretly raise your ...

BioAtla (NASDAQ:BCAB) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints for the OSV ...

Many dedicated dog parents like @hayleyglatfelter know what it's like to rehabilitate a sick dog, but this brave woman has seen her even braver pup, Gideon, endure so much this year. Earlier this fall ...

As of Monday, November 24, Inhibrx Biosciences, Inc.’s INBX share price has dipped by 5.44%, which has investors questioning if this is right time to buy.

The U.S. Food and Drug Administration (FDA) has granted fast track designation to DPTX3186, a first in class oral condensate ...

Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise November 24, 2025 9:00 AM ...

In alignment with the World Health Organization's global strategy, Canada set the ambitious goal to eliminate cervical cancer by 2040. This commitment, led by the Canadian Partnership Against Cancer ...

Earnings call Palvella ended Q3 2025 with $63.6M in cash, supporting operations into H2 2027. The SELVA Phase 3 trial for Qutoran rapamycin in microcystic lymphatic malformations remains on track for ...

In honor of Lung Cancer Awareness Month this November, Flow Space spoke with three experts to clear up misconceptions about ...

A month has gone by since the last earnings report for Regeneron (REGN). Shares have added about 20.2% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the ...

Squamous cell carcinoma (SCC) of the bladder is a distinct and rarer form, accounting for approximately 2% to 5% of all bladder cancers in the U.S. It develops in the flat, thin squamous cells that ...